Task: Answer the multiple-choice question.
Query: Which drug exhibits a -27.388% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a Cl.OC(CNC1CCCC1)COCCOc1ccc(Br)cc1
b CN1C2C=C3C(C#N)=C(N)C(C#N)(C#N)[C@@H](c4cccs4)C3C1CC2
c CCCc1nnc(NC(=O)C(CC)OC(=O)c2cc(C)nc3ccccc23)s1
Answer: a. Cl.OC(CNC1CCCC1)COCCOc1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cl.OC(CNC1CCCC1)COCCOc1ccc(Br)cc1
Cl.OC(CNC1CCCC1)COCCOc1ccc(Br)cc1
1-[2-(4-bromophenoxy)ethoxy]-3-(cyclopentylamino)propan-2-ol;hydrochloride